Acalabrutinib Monotherapy In CLL

Acalabrutinib Monotherapy In CLL

User Photo
ASHReport

1 year
85 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Michelle Dawson Franchise Head Hematology, US Medical Affairs at AstraZeneca Discusses Acalabrutinib Monotherapy In CLL At The 60th ASH Annual Meeting on Dec 1, 2018.
Up Next Autoplay
>